Dr. Amit Basu
Dr. Amit Basu
In practice for
I am licensed to see patients from
3459 5TH AVE
PITTSBURGH , PA 152133236
Grenvale , NY
Pittsburgh , PA 15213
3459 5TH AVE
PITTSBURGH , PA 15213
Greenvale , NY 11548
Education and Training
Medical / Graduate School
Christian Medical College, Dr M G R Medical University, Vellore, Tn, India
The childrens hospital of philadelphia
Long Island Jewish Medical Center
North Shore University Hospital
Immunohistochemical markers of tissue injury in biopsies with transplant glomerulitis.
Hum. Pathol., Jan;43(1):69-80 (2012)
Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation.
J. Pediatr., Jun;148(6):813-8 (2006)
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes.
Transplantation., Dec;82(12):1621-4 (2006)
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection.
Transplantation., Dec;82(12):1649-52 (2006)
Alemtuzumab pretreatment and tacrolimus monotherapy in living-donor liver and kidney transplantation.
Expert Rev Pharmacoecon Outcomes Res., Apr;7(2):113-8 (2007)
Cold heparinized lactated Ringers with procaine (HeLP) preservation fluid in 266 living donor kidney transplantations.
Transplantation., Apr;83(8):1134-6 (2007)
Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy.
Transplantation., Jun;83(12):1563-70 (2007)
Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation.
Am. J. Clin. Pathol., Apr;129(4):587-91 (2008)
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody.
Transplantation., Apr;85(8):1125-32 (2008)
Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney.
Mod. Pathol., Dec;21(12):1490-8 (2008)
Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience.
Transplantation., Dec;86(12):1725-31 (2008)
Neutrophilic tubulitis as a marker for urinary tract infection in renal allograft biopsies with C4d deposition.
Transplantation., Apr;87(7):1013-8 (2009)
Clinicopathologic analysis of patients with BK viruria and rejection-like graft dysfunction.
Hum. Pathol., Sep;40(9):1312-9 (2009)
Kidney after nonrenal transplantation-the impact of alemtuzumab induction.
Transplantation., Sep;88(6):799-802 (2009)
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
Ann. Surg., Oct;238(4):520-5; discussion 525-7 (2003)
Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation.
Clin Transplant., Dec;18(6):661-5 (2004)
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience.
Transplantation., Dec;78(11):1683-8 (2004)
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.
J. Am. Coll. Surg., Apr;200(4):505-15; quiz A59-61 (2005)
Comorbid conditions in kidney transplantation: association with graft and patient survival.
J. Am. Soc. Nephrol., Nov;16(11):3437-44 (2005)
Outcomes of renal transplantation in recipients with peak panel reactive antibody >30% under tacrolimus-based immunosuppression.
Ann. Transplant., 16(3):5-13 (2011)
Clinical course of kidney transplant patients with acute rejection and BK virus replication following Campath therapy.
Clin Transplant., 22(3):348-53 (2008)
Kidney after Extrarenal Transplantation - The Impact of Alemtuzumab Induction.
Transplantation., May;8(Suppl 2):439 (2008)
Single versus en bloc kidney transplantation from pediatric donors less than or equal to 15 kg.
Transplantation., Jul;86(2):264-8 (2008)
Antirejection treatment in kidney transplant patients with BK viruria.
Transplantation., Sep;86(6):797-803 (2008)
HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival.
BMC Nephrol., 11:5 (2010)
Dr. Amit Basu M